Venezuelan pharmaceutical market grew 8.28% by the end of the first two months of 2026

TL;DR

The pharmaceutical sector grew by 8.28% by the end of February 2026, with sales reaching 59,594,219 units.
Local manufacturing laboratories account for 72% of the market's total growth so far this year.
Internal production capacity currently ensures 74% of the pharmaceutical supply in Venezuela.
Generic medications represent 45% of the market, with a growth of 12.27%.
Reduced content presentations (smaller packages) make up 20% of the total market volume.
Demand increased for treatments for central nervous system diseases (+21.64%), diabetes and metabolism (+21.27%), cardiovascular system (+15.55%), and genitourinary products (+14.32%).
The average annual consumption per inhabitant rose to 14.5 units, surpassing the Latin American regional average.
Venezuela has the most competitive prices in Latin America, with an average cost of $5.57 per unit, compared to the regional average of $8.18.

Continuer la lecture de l'article original